{
  "id": "0ff16ac1d63917ca",
  "title": "Early Week 2 Response Predicts Sustained Benefit with Adjunct Cariprazine in MDD",
  "description": "20260105T203000Z",
  "content": "",
  "source": "hcplive.com",
  "source_url": "https://www.hcplive.com/view/early-week-2-response-predicts-sustained-benefit-adjunct-cariprazine-mdd",
  "published_at": "20260105T203000Z",
  "fetched_at": "2026-01-06T00:23:36.488656+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.hcplive.com/view/early-week-2-response-predicts-sustained-benefit-adjunct-cariprazine-mdd",
    "url_mobile": "",
    "title": "Early Week 2 Response Predicts Sustained Benefit with Adjunct Cariprazine in MDD",
    "seendate": "20260105T203000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/hcplive/61140d938b286b9b7f03b1e2218cb34705570cf7-1200x630.png",
    "domain": "hcplive.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}